Directory · CH
Pharmaceutical Manufacturing in Switzerland
A register of firms and the professionals working at them in the Pharmaceutical Manufacturing sector based in Switzerland. Browse the public index, then filter or export on Kipplo.
Companies
618 on file
Mepha Teva Switzerland
Die Mepha Schweiz AG ist eine der führenden Pharmafirmen in der Schweiz und seit 2011 Teil der Teva Gruppe. Zur Mepha Schweiz mit Sitz in Basel gehören die Firmen Teva Pharma AG sowie die Mepha Pharma AG, welche die Nummer eins Position im Schweizer Generikamarkt einnimmt. Die Unternehmensstruktur in der Schweiz Das Unternehmen beschäftigt derzeit 157 Mitarbeitende. Die Vertriebsgesellschaft Mepha Pharma AG vermarktet über 230 Marken- und Nicht-Marken-Generika. Das Mepha-Portfolio deckt rund 20 medizinische Indikationsgebiete ab. Die Medikamente werden an Apotheken, an selbstdispensierende Ärzte, an Drogerien und Spitäler verkauft. Die Vertriebsgesellschaft Teva Pharma AG bietet in der Schweiz über 60 Spezialitäten in den Bereichen zentrales Nervensystem, Krebs und Atemwegserkrankungen an. Zusätzlich zu den qualitativ hochstehenden Medikamenten bieten wir Fachpersonen, Patienten sowie Gesundheitsorganisationen zahlreiche nützliche Dienstleistungen. UNSERE VISION Als Schweizer Unternehmen und Teil von Teva, dem weltweit grössten Generikakonzern, werden wir dank der einzigartigen Kombination aus lokaler Verbundenheit, Internationalität und Innovationskraft den Schweizer Pharmamarkt nachhaltig mitgestalten und prägen. UNSERE MISSION Durch unsere Kundennähe, Innovationskraft sowie qualitativ einzigartigen Medikamente und Dienstleistungen setzen wir uns mit Leidenschaft dafür ein, Patienten Lebensqualität und Gesundheit zu fairen Preisen zu ermöglichen. UNSERE WERTE • Vorausgehen • Fokus und Verantwortlichkeit • Zusammen anpacken • Innovation, wo wir Wert schaffen • Fürsorge • Unsere Familien stolz machen Mepha/Teva Gruppe Die Mepha Schweiz AG ist seit 2011 Teil der Teva Gruppe. Zur Mepha Schweiz mit Sitz in Basel gehören die Firmen Teva Pharma AG sowie die Mepha Pharma AG. Mepha Schweiz Kirschgartenstr. 14, 4051 Basel Mepha Pharma AG, Kirschgartenstr. 14, 4051 Basel Teva Pharma AG, Kirschgartenstr. 14, 4051 Basel
10001+ staff
Divis Laboratories
Divi’s Laboratories Limited is one of the largest API companies in the world, with ~$1.2B in revenue and exporting to more than 100 countries. Established in 1990, we are engaged in the manufacturing of leading generic APIs, Nutraceutical Ingredients and custom synthesis of APIs and Intermediates for global innovator companies primarily for export to regulated markets such as US and Europe. With three manufacturing facilities, market presence across several countries and a team of employees, Divi’s continues to innovate to bring robust techniques to facilitating sustainable manufacturing processes.
10001+ staff
Noramco
Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule
201 to 500 staff
Reata Pharmaceuticals, Inc
Reata Pharmaceuticals has been acquired by Biogen. Please follow along there for the latest news. This page is no longer updated or monitored.
201 to 500 staff
Stallergenes Greer
Stallergenes Greer is a global biopharmaceutical company specialising in allergy therapeutics through the research, development and commercialisation of allergen immunotherapy products and services. Supported by more than 100 years of expertise and innovation, our products are available for patients in over 40 countries. Our purpose is to enable precision medicine to improve life for people with allergies. With more than 1,100 employees worldwide and manufacturing facilities in both Europe and the United States, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy. Link to our privacy policy:
1001 to 5000 staff
Santhera Pharmaceuticals
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need. The Company has an exclusive license from ReveraGen for all indications worldwide to AGAMREE® (vamorolone), a dissociative steroid with novel mode of action, which was investigated in a pivotal study in patients with Duchenne muscular dystrophy (DMD) as an alternative to standard corticosteroids. AGAMREE for the treatment of DMD is approved in the U.S. by the Food and Drug Administration (FDA), in the EU by the European Commission (EC), in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA), in China by the National Medical Products Administration (NMPA), in Hong Kong by the Department of Health (DoH) and in Canada by Health Canada. Santhera has out-licensed rights to AGAMREE for North America to Catalyst Pharmaceuticals and for China and certain countries in Southeast Asia to Sperogenix Therapeutics. For further information, please visit AGAMREE® is a trademark of Santhera Pharmaceuticals.
51 to 200 staff
Deciphera Pharmaceuticals
As a member of ONO Group, Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit
201 to 500 staff
Gedeon Richter - Preglem S.A
PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine. The company was founded in 2006 by Ernest Loumaye, a specialist in female reproductive medicine, and Eric Rolin, a finance executive in the pharmaceutical industry. PregLem’s name reflects the company’s goal of addressing unmet needs in gynaecology and infertility and its geographical location near Lake Geneva (“Lac Leman” in French). PregLem is supported by a Scientific Advisory Board comprising the heads of reproductive medicine departments from major European academic institutions. PregLem’s team expertise is in Clinical Product Development, Regulatory Affairs and Sales and Marketing of innovative products in women’s health. On 7th October 2010, Gedeon Richter Plc. announced the acquisition of PregLem SA and PregLem became a member of the Richter Group.
11 to 50 staff
Ebi-Pharm Ag
Erfolgreich anders seit 1988. Die ebi-pharm ag vertreibt Qualitätspräparate aus der Komplementärmedizin, Kosmetika und weitere Naturprodukte exklusiv an Fachpersonen und den Fachhandel. Als Familienunternehmen mit rund 130 engagierten Mitarbeitenden baut ebi-pharm auf starke und nachhaltige Partnerschaften und setzt im Umgang mit Menschen auf Individualität und Ganzheitlichkeit. Was wir machen, machen wir mit Herzblut!
51 to 200 staff
Galenica
Galenica is the leading fully-integrated healthcare provider in Switzerland. With over 500 own, joint venture and independent partner pharmacies, Galenica operates the largest network of pharmacies in Switzerland. In addition, Galenica further develops and offers well-known own brands and products, exclusive brands and products from business partners as well as a variety of on-site health services and tests for customers. Galenica is also the leading provider of pre-wholesale and wholesale distribution as well as database services in the Swiss healthcare market. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446).
5001 to 10000 staff
Grand Medical Group Ag
Headquartered in Luzern, Switzerland, Grand Medical Group AG began operations over 15 years ago as a health care marketing company. Today, we manufacture a wide range of pharmaceuticals, food supplements and natural products for key therapeutic areas in Africa, Asia and Europe. We specialize in pharmaceutical preparations used in Anti - infective, Anti- osteoporosis, Central Nervous System, Cardiovascular, Immune - suppressants, Gastroenterology, Neurology and Urology. In addition to pharmaceuticals, our offer comprises Food Supplements and Natural Products, which account for a significant part of our product portfolio. The group currently has 3 pharmaceutical manufacturing facilities offering various products in Capsules, Tablets, and Intractable. It recently commissioned a new state-of-the-art manufacturing facility dedicated towards the global supplies of its products in Warsaw, Poland. All our facilities are approved by European Union Regulatory Authorities. Grand Medical Group AG actively exporting to markets spread across Asia, Africa and Europe, and as for today has in portfolio over 75 products and 320 Marketing Authorizations across these regions.
1001 to 5000 staff
Peakdata
PeakData helps pharmaceutical companies learn more about their customers through our agile targeting and segmentation SaaS platform. PeakData is used by more than half of the top 20 Pharmaceuticals and engages 50+ staff in our offices in the USA, Germany, UK, Poland, Netherlands, and Switzerland.
51 to 200 staff
Rontis Corporation
Rontis, a multinational specialty healthcare corporation, was established in 1986 with a vision to provide the most innovative & trustworthy solutions, aiming to become an international leader in the global healthcare industry.
501 to 1000 staff
Senn Chemicals Ag
SENN has been in the peptide business since 1963. From intermediates to cGMP APIs, we have the expertise necessary to optimize processes and streamline scale-up. Discovery through commercial production, we consistently deliver exceptional quality, on time and in budget. From our headquarters near Zurich, Switzerland, SENN serves biotechnology, pharmaceutical, diagnostic, cosmeceutical, and veterinary companies worldwide. Products: Peptides, Amino Acid Derivative, Small Molecule, Nucleotides, Excipients Services: Novel Process Development & Optimization, Analytical Method Development, Scale-Up & Validation, cGMP Manufacturing, Project Management & Regulatory Services
51 to 200 staff
Apr Applied Pharma Research S.A
APR (part of Relief Therapeutics) is a Swiss-based international biopharmaceutical company focused on development and global commercialization of innovative, research-driven products designed to address unmet needs in specialized therapeutic areas and rare diseases. APR combine pharmaceutical development expertise with proprietary drug delivery technologies to realize solutions that meaningfully improve the lives of people with rare diseases and empower families through novel approaches to disease management. A diverse and balanced portfolio of revenue-generating products in all major markets is complemented by a robust pipeline of innovative products at different stages of development for the treatment of recessive metabolic disorders, as well as rare dermatological and ocular diseases. Products are directly commercialized by APR through inhouse sales and marketing teams in strategically important countries across Europe and a growing worldwide network of commercial partners.
11 to 50 staff
Axapharm Ag
axapharm is a Swiss company, which has specialised in marketing high-quality generics, OTC products and medical devices in the Swiss market. axapharm is 100 % self-financed and has around 650 resident pharmacists. axapharm has its own regulatory affairs department and professional marketing structures.
11 to 50 staff
Boehringer Ingelheim Schweiz Gmbh
Boehringer Ingelheim (schweiz) Gmbh is a pharmaceuticals company based out of DUFOURSTRASSE 54, Basel, Switzerland.
10001+ staff
Disch Ag
Disch AG has, founded in 1903, specialized for 120 years in the production of hard-boiled lozenges, toffees and pastilles (gummies). DISCH established itself as a pioneering company in functional confectionery when in 1933, it brought out the well-known «Sportmint» - the first nutraceutical product in history. The refreshing toffee with added vitamin C was a novelty, combining for the first time, a delicious taste in a pleasant chew with the intake of a vitamin. Nutraceuticals were born. Being since then a leading CDMO in confectionery technology, today we focus on the production of pharmaceutical products (OTC) and dietary supplements for customers around the globe. We develop according to our customers' specifications and produce in Switzerland on modern lines according to recognized standards such as GMP. In 2023 we launched for the first time in 40 years own branded DISCH products again. Our premium toffees "Swiss fruit" are functional soft chews of highest quality and with an amazing taste. The range is still to grow. DISCH AG – Innovation meets perfection!
51 to 200 staff
Immunophotonics, Inc
Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate polymer IP-001 for the treatment of solid tumor cancers. IP-001 has unique physio-chemical and immunological properties that allows it to ignite a systemically active cancer immunotherapy from a routine tumor ablation; a minimal invasive intervention that destroys tumors and in doing so liberates tumor antigens. IP-001 enhances interactions of tumor antigens with the immune system, improves the motility of tumor infiltrating T cells, promotes their surveillance of tumor tissue and can generate long-term protective immunity.
11 to 50 staff
Neurimmune Ag
Neurimmune is a biopharmaceutical company translating human immune memory into antibody therapeutics. Neurimmune's Reverse Translational Medicine technology platform translates the genetic information from human white blood cells into selective high-affinity antibody drug candidates. Neurimmune’s pipeline comprises drug candidates for Alzheimer’s disease, amyotrophic lateral sclerosis, fronto-temporal dementia as well as cardiomyopathy and type 2 diabetes.
51 to 200 staff
Psi Cro
PSI is a leading full-service global Contract Research Organization whose key strength is predictable patient enrollment across multiple therapeutic areas. PSI is known in the industry as a CRO focused on ‘on-time project delivery’. This is achieved through investing substantial effort and MD resources into performing quality feasibility assessments that provide an accurate predictor of study timelines. PSI’s global reach allows us to run clinical trials across multiple continents, in 50+ countries around the world. PSI’s reputation is that of a 'no-nonsense' CRO focused on timely patient enrollment and project delivery. An exceptionally high repeat and referral business rates alongside low staff turnover are indicative of our commitment to be the best CRO in the world as measured by our clients and our employees.
1001 to 5000 staff
Sandoz
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc
10001+ staff
Alpex Pharma Sa
Alpex Pharma is a pharmaceutical company active in Research & Development and Production of ODT (Orally Dispersible Tablet) called also “fast melt” and effervescent tablets. Alpex Pharma has developed a unique proprietary covering ODT technology. The high production capacity and advanced R&D technologies makes Alpex Pharma to be one of the most important company of the world in the field of fast melt and effervescent tablets. The company has a state-of-the-art manufacturing and R&D facilities of some square meters, with separate pharmaceutical and nutritional plant GMP compliant.
51 to 200 staff
Ascent Health Services
Negotiating on behalf of over 100 million US healthcare lives- Leading Industry Market Rebates - Transparent Data & Strategic Insights - Dedicated Expert Support Team The Ascent structure allows for our clients to combine their utilization base to achieve deeper brand rebates than if they were negotiating on just their own. Ascent leverages intel and strategies that provide our clients with competitive coverage.
51 to 200 staff
